Additional information This article is part of the Topical Collection on Pharmacology of Acute Care Rights and permissions About this article Cite this article Alshaya, A., Fanikos, J
Not for resale to the general public
The FDA's guidance on blood donor eligibility focuses primarily on medications that could pose risks to recipients or indicate underlying conditions that would disqualify donation
Both agents are in Phase III trials with potential availability within the next few years, assuming successful trial completion and regulatory approval
Youre scaring people. Im like, Yeah, because we as clinicians are scared. We dont think this has to happen
If you want to have your order filled at a local pharmacy instead of via Ready Meds platform, please note that the local pharmacy may charge you a fee for your medication which Ready Med is unable to assist with